BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

AstraZeneca and Qure.ai Hit 5 Million AI-Enabled Chest X-Rays Milestone Across LMICs

AstraZeneca, in partnership with health-tech company Qure.ai, announced the successful completion of 5 million artificial intelligence (AI) enabled chest X...

May 01, 2025 | News

Metabolon Launches Integrated Metagenomics–Metabolomics Platform to Advance Microbiome Research

The combination of metagenomics and metabolomics data, integrated within an intuitive bioinformatics platform, enables deeper microbiome insights than...

April 30, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

April 24, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Earendil Labs and Sanofi Sign $1.72B Licensing Deal for AI-Discovered Bispecific Antibodies Targeting Autoimmune and Inflammatory Bowel Diseases

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi announced that they have entered...

April 18, 2025 | News

Fangzhou Launches AI-Driven Hepatitis Training Center with Guangdong Institute at Liver Disease Forum 2025

Fangzhou Inc., a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the 2025 Greater Bay Area Int...

April 17, 2025 | News

PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Hard-to-Treat Diseases

Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platf...

April 14, 2025 | News

Lunit Study Reveals Trust Gap Between Radiologists and AI in Real-World Breast Cancer Screening in Sweden

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study i...

April 10, 2025 | Report

CAS and Cleveland Clinic Join Forces to Accelerate Drug Discovery and Brain Health Research

CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic ...

April 08, 2025 | News

NUS Researchers Harness AI and 3D Bioprinting to Personalise Gum Tissue Grafts

AI-enabled workflow streamlines oral soft tissue fabrication, paving the way for personalised, less invasive dental treatments A team of researchers from ...

April 07, 2025 | News

FPT and GE HealthCare Strengthen Asia-Pacific Alliance to Drive AI-Enabled Healthcare Innovation

Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and devel...

April 04, 2025 | News

IRBM Launches Advanced Functional Genomics Platform to Power Precision Target Discovery and Validation

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Pl...

April 03, 2025 | News

Lunit Collaborates with U.S. National Cancer Institute to Advance AI-Driven Cancer Research

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a collaboration with the Nationa...

April 01, 2025 | News

KELES and PwC Set Benchmark with First SFDR Article 9 ESG Framework for Digital Health VC

PwC and KELES, the pioneering digital health venture capital (VC) firm, are setting a new standard in digital health investment, leveraging ESG and innovat...

March 28, 2025 | News

Stay Connected